Her primary areas of investigation include Immunology, Atypical hemolytic uremic syndrome, Alternative complement pathway, Complement system and Factor H. Her Immunology research is multidisciplinary, incorporating perspectives in Thrombotic microangiopathy and Kidney disease. Her research in Atypical hemolytic uremic syndrome intersects with topics in Microangiopathic hemolytic anemia, Eculizumab, Preeclampsia and Internal medicine, Disease.
Her Complement system study which covers Complement that intersects with Haemolytic-uraemic syndrome, C3-convertase and End stage renal disease. Her study in Factor H is interdisciplinary in nature, drawing from both Membranoproliferative glomerulonephritis, Glomerulonephritis and Haplotype. Her biological study spans a wide range of topics, including Mutation and Complement factor B.
Véronique Frémeaux-Bacchi mostly deals with Immunology, Atypical hemolytic uremic syndrome, Complement system, Internal medicine and Alternative complement pathway. Many of her studies on Immunology involve topics that are commonly interrelated, such as Transplantation. The Atypical hemolytic uremic syndrome study combines topics in areas such as Thrombotic microangiopathy, Disease, Complement factor B, Eculizumab and Hemolytic anemia.
Her Complement system study combines topics from a wide range of disciplines, such as Molecular biology and Complement. Her Internal medicine research includes themes of Gastroenterology and Endocrinology. Her Alternative complement pathway study combines topics in areas such as Membranoproliferative glomerulonephritis, Glomerulonephritis and Glomerulopathy.
Immunology, Complement system, Atypical hemolytic uremic syndrome, Internal medicine and Eculizumab are her primary areas of study. Within one scientific family, she focuses on topics pertaining to Glomerulopathy under Immunology, and may sometimes address concerns connected to Kidney disease and Nephrotic syndrome. Her primary area of study in Complement system is in the field of Alternative complement pathway.
Her Atypical hemolytic uremic syndrome study incorporates themes from Complement factor I, Discontinuation, Factor H, Hazard ratio and CD46. Her Internal medicine research is multidisciplinary, relying on both Gastroenterology, Endocrinology and Streptococcus pneumoniae. Véronique Frémeaux-Bacchi interconnects Thrombotic microangiopathy, Disease, Retrospective cohort study, Kidney transplantation and Dialysis in the investigation of issues within Eculizumab.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Complement System Part I - Molecular Mechanisms of Activation and Regulation
Nicolas S. Merle;Nicolas S. Merle;Nicolas S. Merle;Sarah Elizabeth Church;Sarah Elizabeth Church;Sarah Elizabeth Church;Veronique Fremeaux-Bacchi;Lubka T. Roumenina;Lubka T. Roumenina;Lubka T. Roumenina.
Frontiers in Immunology (2015)
Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival
Alexandre Loupy;Carmen Lefaucheur;Dewi Vernerey;Christof Prugger.
The New England Journal of Medicine (2013)
Complement System Part II: Role in Immunity.
Nicolas S. Merle;Remi Noe;Lise Halbwachs-Mecarelli;Veronique Fremeaux-Bacchi.
Frontiers in Immunology (2015)
Atypical hemolytic uremic syndrome
Chantal Loirat;Véronique Frémeaux-Bacchi.
Orphanet Journal of Rare Diseases (2011)
Genetics and Outcome of Atypical Hemolytic Uremic Syndrome: A Nationwide French Series Comparing Children and Adults
Véronique Fremeaux-Bacchi;Fadi Fakhouri;Arnaud Garnier;Frank Bienaimé.
Clinical Journal of The American Society of Nephrology (2013)
C3 glomerulopathy: consensus report
Matthew C. Pickering;Vivette D. D'agati;Carla M. Nester;Richard J. Smith.
Kidney International (2013)
Anti–Factor H Autoantibodies Associated with Atypical Hemolytic Uremic Syndrome
Marie-Agnès Dragon-Durey;Chantal Loirat;Sylvie Cloarec;Marie-Alice Macher.
Journal of The American Society of Nephrology (2005)
Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies
Aude Servais;Aude Servais;Laure-Hélène Noël;Lubka T. Roumenina;Moglie Le Quintrec.
Kidney International (2012)
An international consensus approach to the management of atypical hemolytic uremic syndrome in children.
Chantal Loirat;Fadi Fakhouri;Gema Ariceta;Nesrin Besbas.
Pediatric Nephrology (2016)
Pregnancy-Associated Hemolytic Uremic Syndrome Revisited in the Era of Complement Gene Mutations
Fadi Fakhouri;Lubka Roumenina;François Provot;Marion Sallée.
Journal of The American Society of Nephrology (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: